Agraphia — Visual Perceptual Motor Training on Kindergarteners
Citation(s)
Chang SH, Yu NY Visual and Haptic Perception Training to Improve Handwriting Skills in Children With Dysgraphia. Am J Occup Ther. 2017 Mar/Apr;71(2):7102220030p1-7102220030p10. doi: 10.5014/ajot.2017.021311.
Chen YN, Lin CK, Wei TS, Liu CH, Wuang YP The effectiveness of multimedia visual perceptual training groups for the preschool children with developmental delay. Res Dev Disabil. 2013 Dec;34(12):4447-54. doi: 10.1016/j.ridd.2013.09.023. Epub 2013 Oct 11.
Daly CJ, Kelley GT, Krauss A Relationship between visual-motor integration and handwriting skills of children in kindergarten: a modified replication study. Am J Occup Ther. 2003 Jul-Aug;57(4):459-62. doi: 10.5014/ajot.57.4.459.
Dankert HL, Davies PL, Gavin WJ Occupational therapy effects on visual-motor skills in preschool children. Am J Occup Ther. 2003 Sep-Oct;57(5):542-9. doi: 10.5014/ajot.57.5.542.
Feder KP, Majnemer A Handwriting development, competency, and intervention. Dev Med Child Neurol. 2007 Apr;49(4):312-7. doi: 10.1111/j.1469-8749.2007.00312.x.
Hwang YS, Su PF, Hsiao YL, Tsai WH, Hung JY Developing a Nomogram Model to Predict the Risk of Poor Chinese Handwriting in First Grade. Am J Occup Ther. 2020 Sep/Oct;74(5):7405205080p1-7405205080p8. doi: 10.5014/ajot.2020.038711.
Lee TI, Howe TH, Chen HL, Wang TN Predicting Handwriting Legibility in Taiwanese Elementary School Children. Am J Occup Ther. 2016 Nov/Dec;70(6):7006220020p1-7006220020p9. doi: 10.5014/ajot.2016.016865.
Ohl AM, Graze H, Weber K, Kenny S, Salvatore C, Wagreich S Effectiveness of a 10-week tier-1 response to intervention program in improving fine motor and visual-motor skills in general education kindergarten students. Am J Occup Ther. 2013 Sep-Oct;67(5):507-14. doi: 10.5014/ajot.2013.008110.
Poon KW, Li-Tsang CW, Weiss TP, Rosenblum S The effect of a computerized visual perception and visual-motor integration training program on improving Chinese handwriting of children with handwriting difficulties. Res Dev Disabil. 2010 Nov-Dec;31(6):1552-60. doi: 10.1016/j.ridd.2010.06.001.
Prunty M, Barnett AL, Wilmut K, Plumb M Visual perceptual and handwriting skills in children with Developmental Coordination Disorder. Hum Mov Sci. 2016 Oct;49:54-65. doi: 10.1016/j.humov.2016.06.003. Epub 2016 Jun 18.
Ratzon NZ, Efraim D, Bart O A short-term graphomotor program for improving writing readiness skills of first-grade students. Am J Occup Ther. 2007 Jul-Aug;61(4):399-405. doi: 10.5014/ajot.61.4.399.
Tse LF, Thanapalan KC, Chan CC Visual-perceptual-kinesthetic inputs on influencing writing performances in children with handwriting difficulties. Res Dev Disabil. 2014 Feb;35(2):340-7. doi: 10.1016/j.ridd.2013.11.013. Epub 2013 Dec 11.
Tseng MH, Chow SM Perceptual-motor function of school-age children with slow handwriting speed. Am J Occup Ther. 2000 Jan-Feb;54(1):83-8. doi: 10.5014/ajot.54.1.83.
Volman MJ, van Schendel BM, Jongmans MJ Handwriting difficulties in primary school children: a search for underlying mechanisms. Am J Occup Ther. 2006 Jul-Aug;60(4):451-60. doi: 10.5014/ajot.60.4.451.
Effects of Different Visual-perceptual-motor Training Courses on Kindergarten Children
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
